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1. Introduction
Outpatient and short-stay plastic surgery procedures have increased recently up to 457% [1]
due to lower prices, global availability of plastic surgeons, better and safer anaesthetic
techniques. This exponential growth has been increased by greater information in the media,
most notably by means of the enlightenment shown in the internet. Every day more complex
patients force anaesthesiologists to develop better techniques using multimodal approaches
before, during and after anaesthesia. Nowadays it is possible to perform ambulatory plastic
surgery procedures in people with medical conditions that in the past were rejected; myocar‐
dial ischemia, arrhythmias, hypertension, coagulation disorders, lung diseases, diabetes,
etcetera. Improved safety and efficacy in all anaesthesia procedures for plastic surgery is
mandatory; surgeons, patients, relatives and media have their own concerns regarding
anaesthesia patient safety.
Local anaesthesia, plexus nerve blocks and neuroaxial techniques have been reported with
excellent results, as well as patient comfort and acceptance. Spinal, epidural or combined
spinal-epidural procedures are quite safe and have attained widespread use for patients
undergoing ambulatory surgery below the Th3-Th4 spinal level. Spinal anaesthesia for
outpatient and short-stay plastic surgery cases have been well accepted by surgeons and
patients due to its rapid onset and offset, easy administration, minimal expenses, and almost
no side effects or complications. Ambulatory procedures as liposuction, buttocks implants and
calf implants, and many more are done properly under spinal anaesthesia. Longer surgeries
like abdominoplasty, lower body lift, or combined surgeries involving upper and lower body
segments are also done safely under subarachnoid or epidural anaesthesia.[2,3,4] Small gauge
pencil point needles have acceptable rates of 0 to 3 % of postdural puncture headache (PDPH);
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the most fearful side effect of spinal anaesthesia. There are several choices of local anaesthetics
(LAs) available for spinal anaesthesia for ambulatory and short-stay patients, including
ropivacaine, levobupivacaine, racemic bupivacaine, prilocaine, mepivacaine, articaine,
procaine and chloroprocaine. Although controversial, lidocaine is no longer recommended to
be used for spinal anaesthesia. Intraspinal adjuvant drugs like clonidine, dexmedetomidine,
morphine, sufentanyl and fentanyl enhance quality and duration of spinal blocks.
Deep venous thrombosis and pulmonary embolism remains the greatest cause of morbidity
and mortality in plastic surgery.[5,6,7] Spinal anaesthesia decreases these complications as it
facilitates early ambulation. Postoperative pain can be managed with preoperative preemptive
analgesia techniques, plus adjuvant drugs injected into the spinal space.
For the purposes of this review we define outpatient surgery cases as those who are discharged
the same day of the procedure, and short-stay patients those who remain in the surgical unit
or hospital for 24 hours after surgery. This chapter reviews the indications, contraindications,
advantages, disadvantages and drugs used for spinal anaesthesia in ambulatory and short-
stay plastic surgery procedures.
2. Subarachnoid anaesthesia techniques
There are three ways to perform spinal anaesthesia; single injection, combined spinal-epidural,
and continuous subarachnoid anaesthesia with small gauge spinal catheters.
Single injection. Is the most widely used since it is easy to perform, safe, predictable, has low
incidence of side effects, and low cost. The addition of adjuvants drugs to LAs provides
sufficient time for more prolonged plastic surgical procedures, and therefore is the ideal
technique in these patients.[3]
Combined spinal/epidural. Combines the benefits of epidural and subarachnoid anaesthesia,
lessening some of the disadvantages of both procedures. This technique allow us to titrate the
upper sensory level, to reduce total dose of epidural LAs, and to continue anaesthesia as long
as needed.[8,9] It is recommend for long plastic surgeries involving chest, abdomen and
extremities in the same patient. Sometimes it is difficult to keep the epidural catheter in place,
and it can also migrate outside the epidural space.[10,11]
Continuous spinal anaesthesia. Described by Dean in 1907 [12] was reintroduced by Lemmon in
1940 [13]. The technique had several modifications until Hurley and Lambert [14] introduced
the use of thin spinal microcatheters 32-gauge. Nowadays this procedure is underutilized due
to several cases of cauda equina syndrome and the FDA recommendation to withdraw the
technique. The main advantages of continuous spinal anaesthesia is to allow redosing of small
amount of LA to prolong duration of anaesthesia/analgesia and provide better hemodynamic
stability.[15] In the field of plastic surgery outpatient and short-stay cases it may be limited for
older patients with prolonged procedures below Th8 dermatomes.
Spinal anesthesia is done following anatomical landmarks. The introduction of ultrasound in
regional anesthesia is an advanced technique that is now used in difficult cases where anatomy
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cannot be identified properly, or when a difficult block is anticipated as in morbidly obese or
patients with severe anatomic alterations.
3. Indications of spinal anaesthesia
There are two groups of patients who desire plastic surgery procedures: a) Those who undergo
surgery for purely aesthetic reasons to look better and b) Those who do it for work, social or
professional demands. These are patients with special wishes and needs that most of the times
border on perfection, therefore they have poor tolerability for errors or side effects. Compli‐
cations from anaesthesia are not tolerable, even small or insignificant side effects are not
accepted. These patient characteristics demand a careful anaesthesiologist, a cautious anaes‐
thetic plan with some management alternatives ready to be use in order to stay away from
mistakes and complications.
Typically spinal anaesthesia is used for surgical procedures below dermatome Th10, involving
the abdomen, pelvis, perineum, and lower extremities. Outpatient and short-stay plastic
surgery procedures localized up to dermatome Th3-Th4 can be safely done under lumbar
spinal anaesthesia, tilting the surgery table in Trendelemburg or reverse Trendelemburg
position until the desired surgical level is reached. For example, you can use lumbar subar‐
achnoid block for breast surgery and chest/back liposuction, or abdominoplasty combined
with breast surgery.[16,17]
Tables 1 and 2 show our recommendations for outpatient and short-stay cosmetic surgery
procedures that can be done under spinal anaesthesia, including surgeries up to Th3-Th4
dermatomes. In some circumstances it is convenient to use combined epidural-intrathecal
anaesthesia to ensure sufficient anaesthetic duration, as discussed previously.
Surgery Spinal Epidural Spinal-epiduralAnaesthetic Adjuvant Anaesthetic Adjuvant Anaesthetic Adjuvant
Liposuction L, PPX C, F L, PPX C, F L, PPX C, F, S
Liposculpture L, PPX C, F L, PPX C, F L, PPX C, F, S
Buttock Implants/fat
grafting L,PPX C L, PPX C L, PPX C, F, S
Calf Implants L, PPX C L, PPX C L, PPX C, F, S
Breast and
liposuction PPX C, F L, PPX C, F L, PPX C, F. S
Breast only Not recomended Notrecomended L, PPX
Not
recomended Not recomended Not recomended
Perineal procedures L, PPX C, F L, PPX C, F Not recomended Not recomended
L=lidocaine, PPX=Racemic bupivacaine, Levobupivacaine, Ropivacaine, or Mepivacaine
C=Clonidine, F=Fentanyl
Table 1. Ambulatory plastic surgery procedures and neuroaxial anaesthesia.[3]
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Surgery
Spinal Epidural Spinal-epidural
Anaesthetic Adjuvant Anaesthetic Adjuvant Anaesthetic Adjuvant
Abdominoplasty
(Simple, extended or
circular)
PPX C, F, S, or M PPX C, F. M PPX C, F, S, or M
Abdominoplasty with
breast surgery PPX C, F, S, or M PPX C, F, M PPX C, F, S, or M
Lower body lift PPX C, F, S, or M PPX C, F, M PPX C, F, S, or M
Breast pexia Notrecommended
Not
recommended L, PPX C, F
Not
recommended
Not
recommended
L=lidocaine, PPX=Racemic bupivacaine, Levobupivacaine, Ropivacaine, or Mepivacaine,
C=Clonidine, F=Fentanyl. S=Sufentanyl. M=Morphine
Table 2. Short-stay plastic surgery procedures and neuroaxial anaesthesia.[3]
4. Contraindications for spinal anaesthesia
Contraindications are divided into absolute and relative, as shown in table 3. Contraindications
for spinal anaesthesia have been changed over time due to advanced equipment such small
gauge pencil point spinal needles, small gauge Quincke type spinal needles, special tip designs
spinal needles, recent LAs and adjuvants drugs. Patients who wish to fly few days after their
surgery should not receive spinal anaesthesia because of the pressure changes in aircraft cabins
may facilitate cerebrospinal fluid (CSF) leak through the duramater hole. In addition to these
general contraindications, there are few situations where it is not advisable to use spinal
anaesthesia in these patients. For example; patients who live far away from where they are
operated and are not able or willing to return to this facility, should not receive spinal
anaesthesia because the small risk of PDPH. This situation implies that they have to be treated
by colleagues at their city of origin and could facilitate unnecessary medical legal problems.
With plastic surgeons that require longer surgical times it is better to avoid spinal anaesthesia
or advice the patients that they may need general anaesthesia near the end of the procedure.
Absolute
• Patient rejection
• Severe coagulation disorders
• Infection at cutaneous injection site
• Hypovolemia or hemodynamic inestability
• Increased intracranial pressure
Relative
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• Sepsis
• Preexisting diseases of the central nervous system
○ Multiple sclerosis
○ Spina bifida
○ Cancer
○ Hydrocephalus derived
• Anticoagulation
• Thrombocytopenia and thrombasthenia
• Severe anatomical deformities
• Preload dependent conditions
○ Aortic stenosis
○ Obstructive hyperthrophic cardiomiopathy
• Air travel in the immediate post anaesthetic period
Table 3. Spinal anaesthesia contraindications
5. Advantages and complications of spinal anaesthesia
Subarachnoid anaesthesia is an easy procedure that provides a deep and fast surgical block
through the injection of small dose of LA into the lumbar spinal space.[18,19] Even though
lumbar volume of CSF is the main determinant of the effects produced by intrathecal injection
of LA solutions, duration and spread of spinal anaesthesia can be easily manipulated with
type/dose of LAs, baricity of the solution, as well as the addition of preservative free adjuvant
drugs like opioids and/or alpha2-adrenergic agonists.[19,20] Although some aspects of this
technique are controversial, nowadays it is known to be safer than epidural anaesthesia,[21]
with many advantages over other anaesthetic procedures, fewer side effects and uncommon
severe complications.
Advantages. Subarachnoid anaesthesia for ambulatory and short-stay plastic surgery patients
is characterized by rapid onset and convenient offset, quick and simple administration,
inexpensive, with minimal side effects and very few complications. It offers many advantages
for this type of patients as it can be used for procedures below Th3-Th4 such as breast surgery,
abdominal procedures, liposuction and many more surgeries (Tables 1 and 2). The use of small
gauge pencil point spinal needles has reduced to 0-3% the incidence of PDPH, even in young
and outpatients. Spinal anaesthesia is more predictable and safer than epidural or general
anaesthesia. The likelihood of neural damage is reduced when compared to peripheral nerve
blocks. Regional anaesthesia procedures, including subarachnoid anaesthesia, have better pain
control, attenuation of the surgical stress response, preserve perioperative immune function,
better preservation of oxygenation and pulmonary residual functional capacity, improved
visceral vascular flow, early recovery of postoperative ileum, and reduced venous thrombotic
disease and pulmonary embolism.
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Complications and disadvantages. Bradycardia and hypotension are the most frequent cardio‐
vascular side effects associated with spinal anaesthesia and are related to the secondary
sympathetic block. Total dose/volume of injected LAs have a direct relationship with the
cardiovascular response. Bradycardia and arterial hypotension are easy to treat with intrave‐
nous fluids and vasoactive drugs. Sudden cardiac arrest is observed with an estimated
incidence of 0.7 to 0.15%.[22,23,24,25] Changing patient position and hypovolemia are factors
related to sudden cardiac arrest, this situation can take place during extensive liposuction or
abdominoplasty-liposuction. In these patients it is very important to use preventive treatment
as well as to establish proper therapy immediately.
Nerve damage is the most feared side effect of spinal anaesthesia. It can be secondary to local
neurotoxicity of LAs or adjuvant drugs, direct needle damage, haematoma or spinal infection.
Cauda equina syndrome and transitory neurological symptoms (TNS) due to posterior nerve
roots irritation at their entry to the spinal cord [26] are the most neurological controversial side
effects. Several mechanisms have been proposed to explain them. Local neurotoxicity after
spinal injection of any LA is an issue of concern raised after the first published data by
Schneider.[27] Follow up of patients who received uncomplicated spinal anaesthesia had
shown that some developed pain in the buttocks and/or lower extremities after an initial full
recovery from spinal anaesthesia. This painful condition that occurs in the immediate post‐
operative period is known as TNS, and last up to 5 days. Numerous articles have been
published showing that subarachnoid LAs are not free of neurotoxicity; all of them are
neurotoxic when injected inside the spinal space, having a different grade of toxicity.
[27,28,29,30] Takenami et al [26] found in rats that supraclinical concentration of lidocaine
initially is limited to the posterior roots at their entry to the spinal cord. Zong et al found that
spinal ropivacaine 0.75-1.0% induced neurotoxicity after repeated injections in rats; infiltration
of inflammatory cells, vacuolation of myelin sheaths and axons, abnormal morphology of
neurons and apoptosis in the spinal cord, mainly in posterior roots and the adjacent posterior
white matter.[31]
In summary, spinal lidocaine is the most neurotoxic LA, followed in descending order of
toxicity by bupivacaine, levobupivacaine, ropivacaine, articaine, chloroprocaine and procaine.
Postdural puncture headache. This complication is no longer a major concern with a rate of 0 to
3% when pencil point G-27 to G-25, Quincke point G-27,or special tip like Atraucan spinal
needles are used. Even in younger outpatients who were considered at high risk for developing
PDPH, this side effect is seldom observed.[32,33] Post dural puncture headache is attributed
to CSF leak to the extradural space through the hole in the dura. Reina et al [34] found that
G-25 Quincke needles produced well defined dural holes without inflammatory reaction,
while the G-25 Whitacre needles leave a dural hole with separation and disruption of the
collagen fibers and a inflammatory component. They argue that the edema that occurs by this
inflammatory reaction is responsible for the closure of the dural hole, which clinically lowers
the incidence of PDPH by preventing further loss of CSF. Post dural puncture headache can
prolong the convalescence of patients and be a determining factor for hospital readmission.
Seventy to 90% of patients have a spontaneous resolution in one to six weeks after dural
puncture. Conservative management involves bed rest, fluids, analgesics and caffeine.
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Epidural blood patch is seldom needed for PDPH after subarachnoid anaesthesia done with
pencil point needles.
Failed spinal. There are several factors to explain this malfunction; partial position of spinal
needle tip into the subdural or epidural space, inadequate dose, expired LAs, injection into a
dural sac appendix (Tarlov's cyst), low spinal tap, inadequate accumulation of hyperbaric LA
in sacral roots, and on occasions when surgery is prolonged beyond the time of the spinal
anaesthesia.[35] When a subarachnoid block fails, 20-30 minutes must elapse before it is
repeated so as to avoid the possibility of additive effects over the first dose of LA. It is important
to be sure that the first injected LA has reached its maximum effect, if any. Remember that the
spread of LAs may be very slow in some patients, therefore a waiting time of 20 to 30 minutes
ensures that most of the LA which access the subarachnoid space is fixed in the neural tissue.
The second injection done at the same space, or even better in upper spaces, usually produces
a proper subarachnoid block. It has been recommended not to use opioids during the second
attempt (if opioids were used in the first attempt) to avoid eventually delayed respiratory
depression. It is also wise not to use vasoconstrictors in the second injection that could lead to
severe nerve damage by ischemia.[36,37] The addition of clonidine might be safe during the
second spinal block as intratecal doses of this drug are very wide (30 to 450 µg).
Arachnoiditis. Recent studies on the incidence of arachnoiditis secondary to neuroaxial
anaesthesia seems to point out this new entity as a ghost, as a deleterious effect that we must
consider each time that a patient will undergo a neuroaxial injection. This entity may present
initially as TNS, cauda equina syndrome or conus medullaris, and then evolve radiculitis,
fibrosis, scarring of the dural sac, deformities, pachymeningitis, syringomyelia, and pseudo‐
meningocele among others. It has been associated with neuroaxial anaesthesia after traumatic
punctures, LAs, detergents, antiseptics, preservatives and other substances injected by
accident or intentionally into the subarachnoid, subdural or peridural space.[38]
Total spinal block. It can happen during extradural block attempt with inadverted dural
puncture and the injection of high volume of LAs. During spinal anaesthesia LAs seldom reach
an unwanted high metameric level. This situation happens with inappropriate high doses of
LAs, neglect manipulation of patient position when injected with hypo or hyperbaric LAs. If
the level is too high, it may be accompanied by bradycardia, cardiac arrest and or respiratory
failure requiring pharmacologic and ventilatory support.
Bleeding. The development of cerebral or spinal haematomas subsequent to spinal anaesthesia
is a serious and rare complication which mandates prompt diagnosis, and immediate surgery.
A closed claims study in Finland during 2000/2009 [22] found an incidence of neuroaxial
haematoma after spinal anaesthesia of 1:775,000, which is lesser than epidural anaesthesia
1:26,400 and combined epidural-spinal 1:17,800. Castillo et al. in Catalonia Spain [39] reported
an approximated incidence of one haematoma per 150,000 neuroaxial anaesthesias (0.6 per
100,000 spinal anaesthesias versus 0.7 per 100,000 epidural anaesthesias). When performing
neuroaxial anaesthesia it is important to adhere to ASRA guidelines [40] avoiding regional
anaesthesia in patients at risk of bleeding such as coagulation abnormalities, anticoagulation
therapy. Remember that certain conditions like advanced age, anomalies of the vertebral
column or spinal cord, and difficult neuroaxial blocks can increase the risk of bleeding.
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Trauma and infection. There have been reports of nerve damage by direct trauma produced by
the spinal needle, and also there are reports of infections manifested as meningitis or epidural
abscesses after neuroaxial anaesthesia. Instances of either occurrence are exceedingly uncom‐
mon.[25]
As reviewed in the previous paragraphs, severe complications secondary to spinal anaesthesia
are extremely rare and therefore difficult to study. Auroy et al [25] in their prospective study
conducted in France with 756 anaesthesiologists found that the incidence of deleterious events
after regional anaesthesia were rare; they found only 98 incidents in 103,730 cases. There were
40,640 cases of spinal anaesthesia with cardiac arrest in 26 of whom 6 died, (6.4 ± 1.2./ 10,000
patients) which was significant (p <0.05) when compare with other regional anaesthesia
techniques. There were 21 neurological complications (radiculopathy, cauda equina syn‐
drome, paraplegia). Two thirds of the patients with neurologic deficits had either a paresthesia
during needle placement or pain on injection and 75 % of the neurologic deficits after non‐
traumatic spinal anaesthesia occurred in patients who had received 5% hyperbaric lidocaine.
6. Drugs for spinal anaesthesia
There are two groups of drugs used for spinal anaesthesia; LAs and adjuvant drugs. The latter
are used to enhance the performance of spinal anaesthesia and or to lower doses of LAs and
their corresponding side effects. They can be injected through a spinal needle or multiple doses
through a spinal catheter.
Systemic toxicity of LAs is not an issue in subarachnoid anaesthesia, since the dosages used
are very small compared with the epidural doses. However, due to the increasing use of
combined neuroaxial anaesthesia (subarachnoid-epidural) and injections of higher doses of
lidocaine during liposuction, abdominoplasty or neck and face lift, it is important to bear in
mind the possibility of systemic toxicity manifested by seizures, coma, arrhythmias, or heart
failure.
The choice of the spinal LA is determined taking into account the type and duration of plastic
surgery procedures, patient health condition, facilities where the operation is performed, the
experience of the anaesthesiologist, dexterity of surgeons, and availability of drugs. Also, it is
important where the patient lives, or if he/she are tourist patients from a remote place.
The anaesthetic profile of each intrathecal drug is the most important parameter that should
be considered when planning subarachnoid anaesthesia.
Local anaesthetics. Due to the unresolved dispute over local neurotoxicity of intrathecal
lidocaine,[41] some researchers have attempted to determine the usefulness of other LAs in
the field of ambulatory and short-stay surgery, keeping in mind that recovery time after spinal
anaesthesia is important for patients, physicians, third party payers and surgical units. There
are quite a few choices of LAs for outpatient and short-stay spinal anaesthesia; bupivacaine,
levobupivacaine, ropivacaine, mepivacaine, prilocaine, chloroprocaine, procaine, articaine,
and lidocaine.[3,42,43]
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The amino-amide pipecoloxylidides (PPX) family of LAs incorporate four drugs: racemic
bupivacaine, mepivacaine, ropivacaine and levobupivacaine. All of them are used in spinal
anaesthesia for ambulatory cases, in particular bupivacaine. Changes in the total dose and/or
adding some adjuvant drugs has been a growing field in this line of research/clinical practice.
Ropivacaine and levobupivacaine have not been approved all over the world for intrathecal
use, however, multiple reports and the fact that they are made preservatives free make them
safe when injected inside the spinal space.[43,44,45]
In the following paragraphs we briefly review some LAs used in spinal anaesthesia for
outpatient and short-stay cases in various surgical procedures, and analyze their results to use
them in ambulatory and brief-stay plastic surgery patients. We describe the amide class of LAs
first, followed by the ester type.
Lidocaine. Is the most studied/used LA. During the last two decades there has been an increase
in the number of patients implicating lidocaine as a possible source of neurotoxicity resulting
in temporary and permanent neurologic damage after subarachnoid anaesthesia. Nowadays
cauda equina is seldom reported after spinal lidocaine, but TNS are the most reported
deleterious side effects. The risk to develop TNS is significantly higher after spinal lidocaine
compared to spinal bupivacaine, prilocaine, procaine, levobupivacaine, ropivacaine, and
chloroprocaine (7.31 (95% confidence interval (CI) 4.16 to 12.86).[46] Fortunately, TNS
symptoms last no more than five days, without permanent neural damage. Among other
causes, early ambulation is one of the factors that has been associated with the development
of toxicity symptoms, so in ambulatory and short-stay patients spinal lidocaine could be
contraindicated.
Although spinal lidocaine use is controversial, some authors still use it for short procedures.
A dose of 40 mg is sufficient and compared with 7.5 mg of bupivacaine.[19] A dose of 15 mg
of lidocaine plus 15 µg of sufentanyl produces excellent anaesthesia and recovery time better
than 50 mg of lidocaine alone, however 50% develops pruritus.[47] Frey et al compared in
Local anaesthetics Adjuvants
Amino-ester Amino-amide
Procaine Lidocaine Fentanyl
2-cloroprocaine Articaine Sufentanyl
Tetracaine Bupivacaine Morphine
Levobupivacaine Clonidine
Ropivacaine Dexmedetomidine
Mepivacaine
Prilocaine
Etidocaine
Table 4. Drugs for spinal anaesthesia for ambulatory and short-stay plastic surgery procedures
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healthy volunteers [48] 100 mg of lidocaine, bupivacaine 15 mg and 15 mg of tetracaine-the
three hyperbaric-and found that lidocaine has the best recovery profile, although there were
patient dependent variables between the three studied LAs, with some subjects recovering
quickly among those treated with bupivacaine or tetracaine. No major differences were found
between 80 mg of either spinal isobaric lidocaine 2% or spinal isobaric mepivacaine 2% for
ambulatory arthroscopic surgery. Neither group had TNS.[49] Prilocaine, mepivacaine,
articaine, bupivacaine, ropivacaine, and procaine at low doses have been suggested as
alternatives to spinal lidocaine.
Articaine. A 4-methyl-3(2-[propylamino] propionamido)-2-thiophenecarboxylic acid, methyl
ester hydrochloride, originally named carticaine was first prepared by Rusching et al in 1969.
Introduced in dentistry in 1973, it entered clinical practice in Germany in 1976 under the
changed name of articaine. It is the only amide LA that contains a thiophene ring and an
additional ester ring. Recent investigations have demonstrated its usefulness in spinal
anaesthesia for ambulatory short cases. In addition to its fast onset and short duration of motor
blockade, it has low local neurotoxicity.[50,51,52] Doses from 50 to 80 mg of 2% or 3% plain or
hyperbaric articaine produces satisfactory anaesthesia for about 1 hour, with full recovery in
3.5 hours. Hyperbaric articaine was compared with hyperbaric bupivacaine in similar
surgeries, and the results have shown a quicker onset of sensory and sympathetic block in the
articaine group than in the bupivacaine group, but hypotension was more frequent and faster
with articaine.[53] Hendriks et al [54] compared 50 mg of plain articaine versus 50 mg of plain
prilocaine in day-case knee arthroscopy patients and found that full motor function recovery
was shorter after articaine than prilocaine [mean (SD) 140 [33] versus 184 [46] min, respectively,
p<0.001]. Time to spontaneous voiding was shorter after articaine than prilocaine [mean (SD)
184 [39] versus 227 [45] min, respectively, p<0.001]. One patient in the articaine group reported
mild TNS limited to the first postoperative day, but there were no significant differences in
adverse effects between the groups.[50] Addition of fentanyl 10 µg improved analgesia and
reduced postoperative analgesic consumption without prolonging motor block nor delaying
total recovery.[55,56]
Bupivacaine. Is an old drug that has stood the test of time. It is a racemic LA containing two
stereoisomers, S-and R+, the latter being the most toxic. Since the controversy of spinal lidocaine
neurotoxicity, bupivacaine is probably the more used LA in subarachnoid anaesthesia. Its
intrathecal potency is similar to levobupivacaine and stronger than ropivacaine: ratios are 0.97
(95% CI: 0.81-1.17) for levobupivacaine/bupivacaine, 0.65 (95% CI: 0.54-0.80) for ropivacaine/
bupivacaine, and 0.68 (95% CI: 0.55-0.84) for ropivacaine/levobupivacaine.[57] Although it is
an adequate substitute for intrathecal lidocaine for outpatient and short-stay surgery, the usual
doses of 15 to18 mg may be reduced 8 to 10 mg to prevent urinary retention and delayed home
discharge. In addition, almost no possibility of TNS favors the use of bupivacaine for ambu‐
latory plastic surgery. A systematic review by Nair et al [58] suggested that 4-5 mg of hyper‐
baric bupivacaine can effectively produce spinal anaesthesia for knee arthroscopy with
unilateral positioning. Casati et al [59] compared 8 mg 0.5 % hyperbaric bupivacaine versus
sciatic-femoral nerve block with mepivacaine and found that to carry out peripheral nerve
blocks require more time than to perform spinal anaesthesia. Patients under spinal anaesthesia
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had shorter time block, but took longer to urinate without affecting discharge time. A small
dose of 4 mg hyperbaric bupivacaine 0.25% reduces the height of sensory block and motor
block duration. Doses of 3 and 4 mg of spinal hyperbaric 0.5% bupivacaine, with fentanyl 25
µg, or without the opioid can be used safely in lower extremity surgery and can provide rapid
and safe release criteria.[60] Intrathecal injection of 9.7 mg of isobaric bupivacaine acts five
minutes faster than hyperbaric bupivacaine, although at 15 min level of sensory and motor
block have similar characteristics of hyperbaric bupivacaine.[61] For ambulatory cosmetic
short procedures doses of 8 to 10 mg hyperbaric 0.5%-0.75% bupivacaine are adequate, for
short-stay procedures like abdominoplasty plus breast surgery doses from 15 up to 22 mg can
be used safely, but full recovery time will be affected.
Levobupivacaine. It is the last LA introduced in clinical practice back in 1999. It is an L-stereo‐
isomer with a longer duration of action, a clinical profile similar to racemic bupivacaine, but
with less toxicity. The lethal dose of intravenous levobupivacaine is 1.3 to 1.6 times greater
than racemic bupivacaine, and both have equipotent anaesthetic effect via neuroaxial. Some
animal's studies have shown no damage or minimal harm to the spinal cord or cauda equina.
[62,63] In contrast, Takenami et al found axonal degeneration in rats injected with spinal
levobupivacaine.[30] There are numerous clinical studies recommending spinal levobupiva‐
caine in ambulatory surgery. Doses from 7.5 to 15 mg 0.5% hyperbaric/isobaric levobupiva‐
caine produced satisfactory anaesthesia.[64,65] Smaller doses with added adjuvants have been
reported for ambulatory cases; in gynecological patients 3 mg along with 10 µg fentanyl may
be used safely,[66] 5 or 7.5 mg 0.5% intrathecal levobupivacaine plus fentanyl 25 µg for
ambulatory patients undergoing inguinal herniorraphy provides good quality spinal anaes‐
thesia and minimizes the need for intra-operative analgesia.[67] In a double-blinded study
Sanansilp et al [68] compared spinal isobaric or hyperbaric 0.42% levobupivacaine. They found
that hyperbaric levobupivacaine spread higher than the isobaric form, suggesting that the
former is more predictable. In elderly patients spinal levobupivacaine has better hemodynamic
stability compared with bupivacaine.[69]
Although intrathecal levobupivacaine is safe, there have been reported cases of cauda equina
syndrome and TNS. Twenty mg of isobaric levobupivacaine produce less TNS than 80 mg of
isobaric lidocaine (0.33% versus 26.6%, p=0.002).[70] We describe a 38 year old patient who
developed TNS 27 hours after abdominoplasty/liposuction done under spinal anaesthesia with
15 mg of 0.65% hyperbaric levobupivacaine and 30 µg clonidine.[71]
Ropivacaine. Identified by Ekenstam in 1957, ropivacaine was introduced in clinical loco
regional and epidural anesthesia in 1997. It is the first available L-isomer LA for human use.
It is less soluble than bupivacaine, and is the least toxic of the PPX family. The possibility of
TNS is 0-1%. Shortly after its introduction, ropivacaine was safely used for spinal anaesthesia
in the ambulatory setting. It is one third less potent compared to bupivacaine or levobupiva‐
caine.[43] Hyperbaric 0.5% ropivacaine is superior to 0.5% hyperbaric bupivacaine outpatients,
since motor and sensitive block duration are significantly shorter than bupivacaine, with better
cardiovascular stability.[72] Like levobupivacaine, low doses of ropivacaine are useful in
outpatients; several investigative protocols reports small doses from 5 to 10 mg were sufficient
in various types of outpatient surgeries like anorectal,[73] knee arthroscopy,[74] herniorraphy.
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[75] Gautier et al [76] found that 12 mg intrathecal ropivacaine are equivalent to 8 mg of
bupivacaine, with no additional benefits in outpatients undergoing knee arthroscopies. The
accidental injection of 1.0% ropivacaine 30 mg without serious side effects suggests us that
higher doses may be used when are needed for procedures in thoracic dermatomes, even for
ambulatory patients.[77]
Doses from 4 up to 30 mg of isobaric or hyperbaric 0.75 or 1% ropivacaine can be safely used
for ambulatory or short-stay plastic surgery procedures.
Mepivacaine. This LA has been used intrathecally since 1960. It has a short onset with inter‐
mediate duration and low toxicity. Its hepatic metabolism is fast and is excreted by the kidneys.
Its clinical profile is similar to lidocaine, with a relative potency of 1.3:1. Spinal mepivacaine
produces neurological tissue damage with infiltration of macrophages and destruction of the
myelin sheaths and axons in rats. The damage was localized in the proximal portion of the
posterior nerve roots, the entry zone into the spinal cord, or the fasciculus gracilis of the
posterior white mater.[28] Transient neurological symptoms occurs between 0 and 30%. A
study of 1273 ambulatory patients managed with mepivacaine 1.5% intrathecal-epidural or
intrathecal showed that 1.7% of spinal anaesthesia were inadequate and 6.4% had TNS. The
average age of patients who developed TNS was 48 ± 14 years), significantly older than those
who had not TNS (41 ± 16) (p <0.001).[78] Pawlowski et al [79] prospectively studied the
anaesthetic recovery profile in 60 outpatients managed with 60 and 80 mg intrathecal mepi‐
vacaine and concluded that both doses are adequate, although patients who were managed
with 60 mg recovered faster (20 to 30 minutes) without any side effects. The same authors
found no major differences between lidocaine and mepivacaine spinal anaesthesia; time to
ambulation and voiding were longer in patients who received mepivacaine as was time to
epidural first dose. Neither group had TNS symptoms. Lidocaine and mepivacaine are both
appropriate spinal anaesthetics for ambulatory orthopedic lower extremity procedures.[80]
Adding fentanyl 10 µg to 30 mg isobaric spinal mepivacaine 1.5% produces reliable anaesthe‐
sia, hastens block regression, shortens recovery, and facilitates earlier ambulation for patients
undergoing unilateral knee arthroscopy.[81]
2-Chloroprocaine. It is an ester LA suitable for short procedures under spinal anaesthesia.
Preservative free chloroprocaine has been used instead of intrathecal lidocaine in order to
avoid TNS. It has an antagonistic effect on k and µ opioid receptors, which may interfere with
neuroaxial opioid administration. Spinal 2-chloroprocaine, 10 mg/mL 35, 40, 45, 50 and 60 mg
provide consistent sensory and motor block for ambulatory surgery, while reducing the doses
to 35 and 40 mg resulted in a spinal block with faster ambulation. Even though 20 mg and 30
mg doses can produce adequate sensory anaesthesia for short surgical procedures, less motor
block and some sacral sparing should be anticipated. Most studies recommend doses from 30
to 60 mg. A dose of 10 mg produces brief and inconsistent sensory anaesthesia, it can be
considered a no effect dose.[82] Hejtmanek and Pollock [83] review 503 ambulatory patients
managed with spinal chloroprocaine (median dose 40 mg, range 20-60 mg) and found that
times from injection to ambulation and discharge were 107±24 and 171±45 min, respectively,
shorter than spinal lidocaine (155±40 and 224±57 min) (p<0.05), with no reports of TNS.
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Compared with 40 mg articaine, 40 mg of chloroprocaine had similar onset and maximal
spread, but recovery from motor block was clearly faster with chloroprocaine.[84] Adding
fentanyl appears to lengthen the surgical block without prolonging discharge time. Five
possible cases of TNS following spinal chloroprocaine in over 4000 patients, and a regressive
incomplete cauda equina syndrome have been described.[85] To sum up, the short duration
of spinal chloroprocaine makes it a strong contender for outpatient anaesthesia. It appears to
have a lower risk of TNS than lidocaine.
Procaine. This amino-ester LA has been used in the subarachnoid space for short surgeries since
the beginning of last century. Its onset of action is slower than chloroprocaine, and only lasts
30 to 60 minutes. Although procaine produces local toxicity, it is the least neurotoxic LA when
injected inside the spinal space.[28] TNS have an incidence 0 to 6%. Johnson and Swanson [86]
reported a patient with permanent cauda equina syndrome after 150 mg of 10% procaine.
Hodgson [87] used 100 mg hyperbaric spinal procaine versus 50 mg hyperbaric lidocaine in
outpatient arthroscopy and found that the first had a higher rate of anaesthetic failure (17%
versus 3%), and higher incidence of nausea (17% versus 3%). TNS incidence was lower with
procaine (6% vs. 24%). Procaine has been considered as an acceptable alternative to intrathecal
lidocaine in ambulatory patients.
When choosing a LA for subarachnoid anaesthesia it is important to keep in mind that
hyperbaric forms have a wider intrathecal diffusion compared to isobaric solutions, and
therefore they are useful for higher dermatomes surgical procedures. The isobaric LAs are
better for pelvic and lower extremity surgeries. Epinephrine is no longer recommended since
it lengthens recovery time. It is always wise to consider that operating time is longer than the
surgeon's estimate, as there are many timeouts prolonging the surgery. Furthermore, some‐
times the original cosmetic surgical plans are modified during surgery, thereby prolonging
the surgical procedure.[3] Tables 5 and 6 shows LAs and adjuvants mixtures according to the
expected operating times. Note that this includes surgeries less than an hour long, which is
uncommon (review of scars, liposuction of small areas, perineal). For these ultra short cases
the combination of procaine+clonidine+fentanyl is excellent, without the ghost of TNS. Low
doses of PPX local anaesthetics are good, but usually last longer and in a very busy facility,
could prolong discharge. Doses 5 to 8 mg of ropivacaine, bupivacaine or levobupivacaine
provide up to 150 minutes of intrathecal anaesthesia. This is sufficient time for most outpatient
procedures in cosmetic surgery. Prolongation of the action of the LAs by adding clonidine is
dose related; 150 to 300 µg can prolong spinal anaesthesia up to 4-5 hours. Drowsiness,
bradycardia and hypotension are more frequent with the higher doses, but easy to treat.
In our Plastic Surgery Center the most used spinal LA for ambulatory and short-stay patients
are hyperbaric bupivacaine 0.5% and 0.75%, hyperbaric ropivacaine 0.75%, and hyperbaric
levobupivacaine 0.5%. We avoid the use of intrathecal lidocaine. For brief ambulatory cases
we prefer to use low dose of any PPX family LA, plus clonidine 30 to 50 µg. If the ambulatory
procedure is over two hours it is advisable to use regular doses of LAs, and add clonidine in
doses from 75 up to 150 µg. We do not recommend spinal opioids in ambulatory cases given
the likelihood of pruritus and urinary retention. For short-stay long procedures we use
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hyperbaric bupivacaine 15 to 25 mg, hyperbaric ropivacaine 15 to 30 mg, or hyperbaric
levobupivacaine 15 up to 25 mg. Most of our short-stay patients also receive spinal clonidine
150 to 300 µg, with or without fentanyl 12.5 to 25 µg, or sufentanyl 10 µg. Morphine (100 to
200 µg) is seldom used, even in short-stay patients.
Surgery Local anaesthetic concentration and total dose in mg
Ropivacaine 0.75% Levobupivacaine0.75% Bupivacaine 0.5 a 0.75% Lidocaine 2%**
Liposucction with
buttocks fat grafting 10 a 22.5 7.5 – 18 7.5 – 15 50 -100
Liposculpture 10 a 22.5 7.5 – 18 7.5 – 15 50 - 100
Buttocks implants 15 10 10 100
Calf implants 15 10 10 100
Breast implants
combined with body
liposuctionº
22.5 18 18 No
* Hyperbaric local anaesthetics. The addition of adjuvants depends on the expected time of surgery
** Not recommended
º Lumbar approach with hyperbaric local anaesthetic. With or without high lumbar epidural catheter
Table 5. Outpatient plastic surgery procedures and doses of intrathecal local anesthetics *
Estimated surgery time Drugs recommended
Up to one hour
Lidocaine + clonidine
Lidocaine + fentanyl
Articaine + fentanyl
Chloroprocaine + fentanyl or clonidine
Small doses of PPX + fentanyl or clonidine
One to two hours PPX + clonidine or fentanyl
Two to four hours PPX + clonidine or fentanylPPX + clonidine + fentanyl
More than 4 hours PPX + clonidine + fentanylPPX + clonidine + morphine
PPX=Racemic bupivacaine, Levobupivacaine, Ropivacaine, or Mepivacaine
Table 6. Recommended drug combination for spinal anaesthesia according with expected surgery time
Topics in Spinal Anaesthesia52
7. Adjuvant drugs
Adjuvant drugs for spinal anaesthesia in outpatients and short-stay cases are a usual routine
in our daily practice in order to decrease the dose of LAs, facilitate a faster recovery and
effective postoperative analgesia. There are numerous receptors which modulate spinal pain
response, however, there are only a few drugs for subarachnoid use acting as adjuvants.
Adrenaline was the most widely used adjuvant in spinal anaesthesia before the use of
neuroaxial opioids. Its use has been questioned because 100-300 µg added to LAs did not
prolong spinal anaesthesia, but delays recovery. There are some intrathecal adjuvants that
have not been approved to be used in spinal anaesthesia like midazolam, ketamine and
neostigmine. They may also improve the quality of block and prolong analgesia. Intrathecal
magnesium sulphate mainly potentiates the analgesic action of intrathecal opioids, without
significant side effects. A positive impact on spinal analgesia has also been suggested for
intrathecal calcium channel blockers, and nonsteroidal anti-inflammatory drugs. Alpha2
agonists and opioids are the most used spinal adjuvants drugs.
Alpha2 agonists. Alpha2 agonists drugs are being increasingly used in critical care and anaes‐
thesia. Beside analgesia and sedation, they also decrease sympathetic tone and attenuate the
stress response to anaesthesia and surgery. Historically, adrenaline was the first alpha2 agonist
used intrathecally but it is no longer recommended. Clonidine and dexmedetomidine are also
members of this group of adjuvant drugs. Their site of action involves specific receptors of the
spinal dorsal horn and supraspinaly in the nucleus coereleus in the pons. Spinal injection of
clonidine and dexmedetomidine enhance duration and quality of subarachnoid anaesthesia
without neurotoxicity. Continuous administration of spinal clonidine in Wistar rats during 14
days failed to demonstrate neurotoxic damage.[88] Erddivanli and coworkers injected male
Sprague-Dawley rats [89] with 3 µg and 10 µg of intrathecal dexmedetomidine added to
bupivacaine found no apparent pathohistological changes 24 hours after a single injection. In
male Kunming mice 1 to 3 µg of dexmedetomidine displayed a robust analgesia via a α2-
receptor in a dose dependent manner and no significant pathological impacts on the spinal
cord were noticed, with a potential protective effects of lidocaine induced neural cell damage.
[90]
Clonidine. Is an alpha2 agonist used in anaesthesia for various purposes. When injected
neuroaxialy, it prolongs sensory and motor block, increases sedation and may potentiate
hypotension and bradycardia. It has been extensively studied in high (> 150 µg), low (< 150
µg) and small (< 75 µg) doses. Doses of 150, 300 and 450 µg produce dose dependent analgesia,
[91] and enhance spinal anaesthesia, with relative hemodynamic stability. Doses of 15 and 30
µg in addition to 11 mg of spinal hyperbaric bupivacaine [92] provide better sensory and motor
block compared to bupivacaine alone, but clonidine 30 µg was associated with more incidence
and duration of hypotension. Mirivirta et al used 15 µg of clonidine in lateral spinal anesthesia
with hyperbaric bupivacaine 5 mg [93] in outpatients undergoing knee arthroscopy reporting
intensified spinal lateral anaesthesia without affecting home-readiness. A systematic review
[94] including 1,445 patients using a wide variety of spinal clonidine doses as adjuvant to
subarachnoid bupivacaine, mepivacaine, prilocaine, or tetracaine found that 15 to 150 µg
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prolonged in a linear, dose-dependent manner, the time to 2 segment regression (range of
means, 14 to 75 minutes) and also delayed the time to regression to L2 (range of means, 11 to
128 minutes). The time to first analgesic request (median 101 minutes, range 35 to 310) and of
motor block (median 47 minutes, range 6 to 131) was extended with no relation to dose. There
were fewer episodes of intraoperative pain with clonidine (relative risk, 0.24; 95% confidence
interval [CI], 0.09-0.64; number needed to treat, 13) but more episodes of arterial hypotension
(relative risk, 1.81; 95% CI 1.44-2.28; number needed to harm, 8) without evidence of dose-
responsiveness. The risk of bradycardia was unchanged.
The optimal dose of spinal clonidine remains unknown. In our current practice, for short
ambulatory procedures we use clonidine 30 to 50 µg added to LA without negative impact on
home discharge criteria. For short-stay plastic surgery we use from 75 up to 300 µg of clonidine
as adjuvant for any PPX family local anaesthetics.
Dexmedetomidine. Is the newest agent in this group. It was approved by FDA in 1999 for use in
humans for analgesia and sedation in the intubated patients at the intensive care settings. It
has a α2/α1 selectivity ratio which is eight to 10 times higher than that of clonidine. Although
it has not been approved for spinal use, there is some research that shows its safety and
effectiveness by prolonging time of sensory and motor block of subarachnoid anaesthesia.
Kanasi and coworkers [95] compared spinal dexmedetomidine 3 µg versus spinal clonidine
30 µg added to 12 mg subarachnoid bupivacaine versus plain bupivacaine. They found that
both alfa2 agonists shorten onset time of motor block and significantly prolonged sensory and
motor times. The mean time of sensory regression to the S1 segment was 303 ± 75 minutes in
dexmedetomidine patients, 272 ± 38 minutes in those who received clonidine and 190 ± 48 min
in control group. The regression of motor block to Bromage 0 was 250 ± 76 minutes in dexme‐
detomidine group, 216 ± 35 minutes in clonidine cases and 163 ± 47 minutes in control group.
The onset and regression times were not significantly different between groups treated with
both alfa2 agonists. The mean arterial pressure, heart rate and level of sedation were similar
in the three groups intraoperatively and postoperatively. Five µg of dexmedetomidine added
to 0.75 isobaric ropivacaine prolonged duration of motor and sensory block, and enhance post
operatory analgesia,[96] and significantly prolonged sensory and motor block and reduced
demand of rescue analgesics in 24 hours when compared with 25 µg fentanyl and 30 µg
clonidine when added to 12.5 mg hyperbaric bupivacaine for spinal anaesthesia.[97] In elderly
patients managed with 6 mg 0.5% spinal bupivacaine, the addition of only 3 µg of dexmede‐
tomidine accelerated the blockade onset and prolonged the duration of anaesthesia and
postoperative analgesia, although recovery of motor block was affected.[98]
It has been shown that intravenous dexmedetomidine and clonidine significantly prolong
bupivacaine spinal anaesthesia, with good sedation effect and hemodynamic stability. In 2003
Rhee et al [99] published the first clinical article with intravenous clonidine to prolong spinal
anaesthesia; iv. clonidine 3µg/ kg-1 during 10 min immediately after the subarachnoid block
or at 50 min after spinal anaesthesia, prolonged significantly duration of motor and sensory
block for approximately one hour. In 2007 we found that dexmedetomidine i.v. also improves
bupivacaine spinal anaesthesia.[100] In our research we use an i.v. infusion of 1 µg/Kg
dexmedetomidine given in 20 min, followed by 0.5 µg/kg/h dexmedetomidine drip until end
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of surgery. A comparative group was treated with clonidine 4 µg/kg, given in 20 min i.v.
infusion started 20 min after the spinal block, and followed by a 0.9% saline drip until the end
of surgery. Sensory block duration was longer in both groups, 208±43.5 and 225±58.8 min
respectively, vs. placebo group 137±121.9 min (p=0.05). Motor block duration was longer in
clonidine than dexmedetomidine (191±49.8 and 172±36.4) vs. placebo group (172±36.4) without
significative statistical difference. Other authors have confirmed our initial results using i.v.
dexmedetomidine doses from 0.25 to 0.5 µg/kg as an initial bolus, followed or not by an
infusion of 0.5 µg/kg/h.[101, 102, 103] Two meta-analysis [104,105] showed that i.v. dexmede‐
tomidine prolonged the duration of spinal anaesthesia and improved postoperative analgesia
without increasing the incidence of hypotension and adverse events. Transient reversible
bradycardia was a mild side effect.
Opioids. Since Yask and Rudy demonstrated that intrathecal opioids produced potent and
selective analgesia, neuroaxial opioids are the drugs most used for this purpose. All opioids
administered intrathecally will produce some degree of spinally mediated analgesia. The
major differences are related to their solubility characteristics and their effect on duration of
action, clearance rate, and side effects. Experimental and clinical studies have demonstrated
that after their neuroaxial injection, opioid liposolubility is inversely proportional to their
spinal selectivity, which is higher for the most water-soluble drugs, morphine and hydromor‐
phone, than for other more lipophilic drugs, such as fentanyl and sufentanyl.[107] Morphine
significantly prolongs spinal analgesia and fentanyl and sufentanyl enhance and moderately
prolong the sensory block without affecting motor function. Nausea, vomiting, pruritus, and
urinary retention are frequent side effects, respiratory depression is seldom observed.
Morphine. Although spinal morphine is the gold standard for opioid neuroaxial post operatory
analgesia, it is not the best choice for ambulatory nor short-stay surgery due to a greater
incidence of adverse effects that requires cautious patient selection and monitoring. Morphine
produces intense analgesia for up to 24-30 hours with doses as low as 100 µg. In our practice
we avoid its use in plastic surgery patients.
Fentanyl. Is the most suitable opioid for ambulatory surgery patients. It has the strongest effect
at the spinal cord administered spinally or epidurally, producing a short-term analgesia (1-4
hours), which is very helpful in acute postoperative pain. It has been used together with most
local anaesthetics in doses from 10 µg up to 25 µg providing selective intra and postoperative
analgesia, patient satisfaction, without delaying recovery time.[55,56,60,66,67,107,108,109,110]
The most recommended doses are 20 and 25 µg in different outpatient scenarios. Levobupi‐
vacaine 3 mg plus 10 µg fentanyl may be used as a suitable alternative to 10 mg lidocaine plus
10 µg fentanyl for subarachnoid anaesthesia of short duration. It achieved a clinically equiv‐
alent time for resolution of sensory block, similar intraoperative conditions, and comparable
patient satisfaction.[111] The most common side effects are nausea, vomit and itching can be
prevented or treated with nalbuphine, droperidol,[112], propofol or ondansetron.
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8. Criteria for home discharge
Outpatient plastic surgery patients managed with spinal anaesthesia must meet established
home discharge criteria. The goal of these criteria is to discharge patients safely and avoid
hospital readmissions due to complications. Pain, nausea, vomiting, and urinary retention are
common examples. It is not entirely necessary to fulfill 100% of these home discharge stand‐
ards, but patients should be warned about the gradual disappearance of spinal anaesthesia
side effects, and facilitate easy communication with the surgical unit, the surgeon and
anaesthesiologist. These patients require postanaesthetic and appropriate postoperative
orders, transportation, and occasional professional company. It is vital that each unit defines
its own ambulatory surgery discharge criteria, according to the characteristics and specific
needs of their patients.[3,4] Table 7 shows the most common discharge criteria.
Hemodynamic stability Vital signs return to pre-anaesthetic values is mandatory
Full alertnesss Patient awake, well oriented. Spinal anaesthesia promotes alertness which facilitates
optimal conditions for early home discharge
Permeable digestive tract Tolerance to solid or liquid intake without nausea or vomiting
Without or mild pain Controlled postoperative pain (VAS <2/10) with oral analgesics. Spinal anaesthesia
with adjuvants provides an extended period of analgesia, it does facilitate early
home discharge and reduce analgesics needs.It is desirable to prescribe a
combination of opioid and non-opioid analgesics for expected postoperative pain
and patient profile.
Spontaneous bladder voiding This is a controversial requirement. Some centers consider it as mandatory to prevent
readmissions for distended bladder. In our practice we do not consider this
requirement as essential and the patient knows the remote possibility of urinating
difficulties. We avoid the use of intrathecal opioids to reduce this risk.
Ability to walk Complete regression of motor block is convenient. The patient may try to walk when
perianal sensitivity has been recovered, and is able to flex and extend the foot. In
some cases it is feasible to discharge without 100% motor recovery.
Headache While classical PDPH occurs after 2 to 5 days after spinal anaesthesia, there are
patients that may develop it in the immediate postoperative period. It is wise to
investigate PDPH symptoms with the patient seated or in a standing position.
Others No surgical bleeding, guaranteed companionship during recovery, transportation
and accommodation, do not drive. Keep an established secure communication such
as telephone, FAX, e-mail.
Table 7. Home discharge criteria
9. Conclusions
Outpatient and short-stay plastic surgery cases have grown exponentially worldwide.
Anaesthesiologists need to provide a safe anaesthesia to these patients who are often subjected
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to prolonged surgeries with risks that are higher than expected. Nowadays most cosmetic
operations can be done in outpatient and short-stay facilities thanks to advances in anaesthesia.
Although most anesthesiologists use general anesthesia for these procedures, regional
anesthesia techniques have demonstrated certain advantages such as better pain control,
attenuation of the surgical stress response, preserves perioperative immune function, better
preservation of oxygenation and lung residual functional capacity, improved visceral vascular
flow, less bleeding, early recovery of postoperative ileum, and reduced venous thrombotic
disease and pulmonary embolism.
Spinal anaesthesia is a simple technique, with a small volume of drugs producing profound
anaesthesia and analgesia, and is devoid of systemic pharmacologic side effects. There are
many choices of LAs for outpatient and short-stay spinal anaesthesia; for ultra short proce‐
dures the best choice are procaine, articaine or lidocaine. For intermediate duration procedures
small doses of intermediate duration LAs, or even lidocaine can be used. For longer procedures
bupivacaine, levobupivacaine, and ropivacaine are excellent agents. Addition of adjuvant
drugs to LAs enhance subarachnoid anaesthesia with better recovery according with expected
surgical time, low incidence of side effects or complications, and longer postoperative
analgesia. Clonidine and dexmedetomidine accelerate the onset and prolong the duration of
spinal anaesthesia and analgesia.
Severe complications after spinal anesthesia are exceedingly rare; cardiac arrest, meningitis,
intracranial subdural hematoma, spinal epidural hematoma, TNS and cauda equina syn‐
drome. Patients should be informed in detail regarding the incidence, severity, and outcome
of these complications.
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